Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral polio vaccine for short-term prevention of COVID-19
IRCT20140428017469N1Phase 3Completed
- Sponsor
- Petroleum Industry Health Organization
- Start
- Jun 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of trivalent oral poliovirus vaccine in coronavirus disease 2019 (COVID-19), sponsored by Petroleum Industry Health Organization. Primary endpoint: Adjusted Incidence (Risk) Ratio of COVID-19. Started Jun 2020; status: completed.
02
Drugs
trivalent oral poliovirus vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20140428017469N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140428017469N1.